Research in the laboratory is focused on vascular biology and how changes in the vasculature can affect heart disease, stroke, and cancer. The studies correlate microscopy and biochemistry evidence to determine what changes occur and how these changes affect the disease process. Currently, three interrelated studies are ongoing.

In the first, we are trying to learn why in atherosclerosis the lysosomes of macrophages and smooth muscle cells in the artery wall become bloated with cholesterol. To do this, we use cultured macrophages and look at the uptake and processing of cholesterol. The cholesterol is delivered to the cells within modified lipoproteins. This is similar to what occurs in vivo. We compare quantitative microscopic observations on the uptake and fate of the lipoproteins with measures of key biochemical pathways in cholesterol metabolism. In this way we are beginning to dissect why lysosomes cannot clear their cholesterol load. To relate these tissue culture experiments to the disease process, we also compare the appearance of these tissue culture cells to that exhibited by cells during various stages of atherosclerosis. This is also allowing us to investigate the effect this bloating has on progression of the disease. Among our findings, we have shown that lysosomal cholesterol accumulation occurs in two stages. In the initial stage, cholesteryl esters delivered by lipoproteins are broken down in th lysosome but the resulting unesterified cholesterol cannot escape the lysosome. In later stages, and perhaps related to the free cholesterol accumulation, hydrolysis of the cholesteryl esters is inhibited. This produces lysosomes rich in both free and esterified cholesterol.

In the second set of studies, we are exploring how triglycerides can alter intracellular cholesterol metabolism. We have found that triglycerides significantly increase the rate of cholesterol metabolism and cellular clearance of cholesterol. We are now trying to define the mechanisms by which this occurs.

In a new line of investigation in the laboratory, we are investigating how inhibition of cholesterol use can effect cell proliferation. Under conditions where cholesterol is scarce, cell proliferation, such as that seen in tumors, is slowed. The cell can acquire cholesterol exogenously or synthesize it internally. Each pool of cholesterol appears to have a slight different trafficking mechanism within the cells. It is still not clear whether an inhibition of use of one pool can be compensated by use of cholesterol from the other pool. Cholesterol restriction is a potential means of slowing some tumor growth. However, to fully understand the potential, much more knowledge of cholesterol trafficking and utilization within different cell types is required. . . .


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. 7-Ketocholesterol in disease and aging. Anderson A, Campo A, Fulton E, Corwin A, Jerome WG, O'Connor MS (2020) Redox Biol : 101380
    › Primary publication · 31926618 (PubMed) · PMC6926354 (PubMed Central)
  2. Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study. Salisbury-Ruf CT, Bertram CC, Vergeade A, Lark DS, Shi Q, Heberling ML, Fortune NL, Okoye GD, Jerome WG, Wells QS, Fessel J, Moslehi J, Chen H, Roberts LJ, Boutaud O, Gamazon ER, Zinkel SS (2018) Elife
    › Primary publication · 30281024 (PubMed) · PMC6234033 (PubMed Central)
  3. A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. Cooke AL, Morris J, Melchior JT, Street SE, Jerome WG, Huang R, Herr AB, Smith LE, Segrest JP, Remaley AT, Shah AS, Thompson TB, Davidson WS (2018) J Lipid Res 59(7): 1244-1255
    › Primary publication · 29773713 (PubMed) · PMC6027914 (PubMed Central)
  4. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function. May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS (2018) J Biol Chem 293(24): 9176-9187
    › Primary publication · 29712723 (PubMed) · PMC6005447 (PubMed Central)
  5. Microsomal triglyceride transfer protein contributes to lipid droplet maturation in adipocytes. Swift LL, Love JD, Harris CM, Chang BH, Jerome WG (2017) PLoS One 12(8): e0181046
    › Primary publication · 28793320 (PubMed) · PMC5549975 (PubMed Central)
  6. Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease. McClure R, Ong H, Janve V, Barton S, Zhu M, Li B, Dawes M, Jerome WG, Anderson A, Massion P, Gore JC, Pham W (2017) J Alzheimers Dis 55(2): 797-811
    › Primary publication · 27802223 (PubMed) · PMC5848215 (PubMed Central)
  7. Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle. Talati MH, Brittain EL, Fessel JP, Penner N, Atkinson J, Funke M, Grueter C, Jerome WG, Freeman M, Newman JH, West J, Hemnes AR (2016) Am J Respir Crit Care Med 194(6): 719-28
    › Primary publication · 27077479 (PubMed) · PMC5027228 (PubMed Central)
  8. Microsomal Triglyceride Transfer Protein (MTP) Associates with Cytosolic Lipid Droplets in 3T3-L1 Adipocytes. Love JD, Suzuki T, Robinson DB, Harris CM, Johnson JE, Mohler PJ, Jerome WG, Swift LL (2015) PLoS One 10(8): e0135598
    › Primary publication · 26267806 (PubMed) · PMC4534446 (PubMed Central)
  9. Quantification of acute vocal fold epithelial surface damage with increasing time and magnitude doses of vibration exposure. Kojima T, Van Deusen M, Jerome WG, Garrett CG, Sivasankar MP, Novaleski CK, Rousseau B (2014) PLoS One 9(3): e91615
    › Primary publication · 24626217 (PubMed) · PMC3953437 (PubMed Central)
  10. Whole-cell analysis of low-density lipoprotein uptake by macrophages using STEM tomography. Baudoin JP, Jerome WG, Kübel C, de Jonge N (2013) PLoS One 8(1): e55022
    › Primary publication · 23383042 (PubMed) · PMC3561407 (PubMed Central)
  11. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V (2012) J Am Coll Cardiol 60(23): 2372-9
    › Primary publication · 23141484 (PubMed)
  12. Regulation of late endosomal/lysosomal maturation and trafficking by cortactin affects Golgi morphology. Kirkbride KC, Hong NH, French CL, Clark ES, Jerome WG, Weaver AM (2012) Cytoskeleton (Hoboken) 69(9): 625-43
    › Primary publication · 22991200 (PubMed) · PMC3746372 (PubMed Central)
  13. Reovirus replication protein μ2 influences cell tropism by promoting particle assembly within viral inclusions. Ooms LS, Jerome WG, Dermody TS, Chappell JD (2012) J Virol 86(20): 10979-87
    › Primary publication · 22837214 (PubMed) · PMC3457141 (PubMed Central)
  14. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. Sorci-Thomas MG, Owen JS, Fulp B, Bhat S, Zhu X, Parks JS, Shah D, Jerome WG, Gerelus M, Zabalawi M, Thomas MJ (2012) J Lipid Res 53(9): 1890-909
    › Primary publication · 22750655 (PubMed) · PMC3413229 (PubMed Central)
  15. Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation. Cai Q, Brissova M, Reinert RB, Pan FC, Brahmachary P, Jeansson M, Shostak A, Radhika A, Poffenberger G, Quaggin SE, Jerome WG, Dumont DJ, Powers AC (2012) Dev Biol 367(1): 40-54
    › Primary publication · 22546694 (PubMed) · PMC3391601 (PubMed Central)